TransMedics (TMDX) Share-based Compensation Growth (3y) (2021 - 2026)
Powered by 
Analysis
TransMedics (TMDX) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 8.37% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -22.92% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 19.64% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -28.31% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 0.55% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 4.11% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 7.30% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -0.59% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 3.40% |
| 10 | TransMedics | 3.12 Bn | 2.64 Bn | 113.20 Mn | 122.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.21% |
| Mar 31, 2026 | 147.02% |
| Dec 31, 2025 | 46.45% |
| Sep 30, 2025 | 192.26% |
| Jun 30, 2025 | 59.35% |
| Mar 31, 2025 | 57.11% |
| Dec 31, 2024 | 75.70% |
| Sep 30, 2024 | 59.09% |
| Jun 30, 2024 | 61.69% |
| Mar 31, 2024 | 60.68% |
| Dec 31, 2023 | 101.66% |
| Sep 30, 2023 | 28.14% |
| Jun 30, 2023 | 98.80% |
| Mar 31, 2023 | 116.76% |
| Dec 31, 2022 | 119.71% |
| Sep 30, 2022 | 109.28% |
| Jun 30, 2022 | 119.17% |
| Mar 31, 2022 | 243.49% |
| Dec 31, 2021 | 236.71% |
| Sep 30, 2021 | 299.26% |